Items where authors include "van Eijk, R.P.A."

Article

Benatar, M. orcid.org/0000-0003-4241-5135, McDermott, C. orcid.org/0000-0002-1269-9053, Turner, M.R. et al. (1 more author) (2025) Reply: Overstating harms can have consequences. Brain, 148 (6). awaf047. ISSN 0006-8950

McDonough, H., McFarlane, R. orcid.org/0000-0001-7380-4219, Caravaca Puchades, A. et al. (26 more authors) (2025) Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 20-29. ISSN 2167-8421

Caravaca Puchades, A., McDonough, H.E., Al-Chalabi, A. et al. (26 more authors) (2025) Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 8-19. ISSN 2167-8421

van Eijk, R.P.A. orcid.org/0000-0002-7132-5967, Weemering, D.N. orcid.org/0009-0005-4182-3294, Opie-Martin, S. et al. (27 more authors) (2025) Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup 1). pp. 30-40. ISSN 2167-8421

Vasta, R., Ombelet, F., Hobin, F. et al. (26 more authors) (2025) Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 50-60. ISSN 2167-8421

Sennfält, S., Al-Chalabi, A., Caravaca Puchades, A. et al. (26 more authors) (2025) Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (sup1). pp. 61-72. ISSN 2167-8421

Musson, L.S. orcid.org/0000-0002-1246-2734, Mitic, N. orcid.org/0009-0002-5397-0206, Leigh-Valero, V. orcid.org/0009-0008-3413-8741 et al. (15 more authors) (2025) The use of digital devices to monitor physical behavior in motor neuron disease: systematic review. Journal of Medical Internet Research, 27. e68479. ISSN 1438-8871

Benatar, M. orcid.org/0000-0003-4241-5135, McDermott, C. orcid.org/0000-0002-1269-9053, Turner, M.R. orcid.org/0000-0003-0267-3180 et al. (1 more author) (2025) Rethinking phase 2 trials in amyotrophic lateral sclerosis. Brain, 148 (4). pp. 1106-1111. ISSN 0006-8950

Genge, A., Cedarbaum, J.M., Shefner, J. et al. (19 more authors) (2024) The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25 (3-4). pp. 382-387. ISSN 2167-8421

Helleman, J., Johnson, B., Holdom, C. et al. (12 more authors) (2022) Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease : an international survey. Journal of Neurology, 269 (11). pp. 6003-6013. ISSN 0340-5354

van Eijk, R.P.A., Nikolakopoulos, S., Roes, K.C.B. et al. (14 more authors) (2021) Innovating clinical trials for amyotrophic lateral sclerosis : challenging the established order. Neurology, 97 (11). pp. 528-536. ISSN 0028-3878

van Eijk, R.P.A., Beelen, A., Kruitwagen, E.T. et al. (16 more authors) (2021) A road map for remote digital health technology for motor neuron disease. Journal of Medical Internet Research, 23 (9). e28766. ISSN 1438-8871

van Eijk, R.P.A., de Jongh, A.D., Nikolakopoulos, S. et al. (4 more authors) (2021) An old friend who has overstayed their welcome : the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22 (3-4). pp. 300-307. ISSN 2167-8421

van Eijk, R.P.A., Kliest, T., McDermott, C.J. orcid.org/0000-0002-1269-9053 et al. (12 more authors) (2020) TRICALS: creating a highway toward a cure. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21 (7-8). pp. 496-501. ISSN 2167-8421

van Eijk, R.P.A., Nikolakopoulos, S., Roes, K.C.B. et al. (7 more authors) (2019) Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials. Journal of Neurology, Neurosurgery & Psychiatry, 90 (12). pp. 1331-1337. ISSN 0022-3050

Westeneng, H.-J., Debray, T.P.A., Visser, A.E. et al. (44 more authors) (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurology, 17 (5). pp. 423-433. ISSN 1474-4422

van Eijk, R.P.A., Jones, A.R., Sproviero, W. et al. (19 more authors) (2017) Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology, 89 (18). pp. 1915-1922. ISSN 0028-3878